Akero Therapeutics OverviewAkero Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for AKRO.
Quarterly EBIT
-$80.47M
↑ 1.51% YoY
As of Sep 30, 2025
Annual EBIT (TTM)
-$299.51M
↓ 11.23% YoY
Trailing 12 months ending Sep 30, 2025
Akero Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for AKRO.
As of Sep 30, 2025
Trailing 12 months ending Sep 30, 2025